Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-5-21
pubmed:abstractText
Folate receptor alpha (FOLR1) is a membrane bound receptor involved in the transport of folate as well as other regulatory cellular processes. The purpose of this study was to examine the expression of FOLR1 in uterine cancers and to identify changes in gene expression that are associated with overexpression of FOLR1.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0090-8258
pubmed:author
pubmed:issnType
Print
pubmed:volume
105
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
563-70
pubmed:dateRevised
2011-10-26
pubmed:meshHeading
pubmed-meshheading:17400285-Carcinoma, Endometrioid, pubmed-meshheading:17400285-Carrier Proteins, pubmed-meshheading:17400285-Cystadenocarcinoma, Serous, pubmed-meshheading:17400285-Female, pubmed-meshheading:17400285-Folate Receptor 1, pubmed-meshheading:17400285-Folate Receptors, GPI-Anchored, pubmed-meshheading:17400285-GPI-Linked Proteins, pubmed-meshheading:17400285-Gene Expression, pubmed-meshheading:17400285-Humans, pubmed-meshheading:17400285-Immunohistochemistry, pubmed-meshheading:17400285-Membrane Glycoproteins, pubmed-meshheading:17400285-Mixed Tumor, Mullerian, pubmed-meshheading:17400285-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:17400285-Polymerase Chain Reaction, pubmed-meshheading:17400285-RNA, Messenger, pubmed-meshheading:17400285-Receptors, Cell Surface, pubmed-meshheading:17400285-Uterine Neoplasms
pubmed:year
2007
pubmed:articleTitle
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma.
pubmed:affiliation
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology and the United States Military Cancer Institute, Walter Reed Army Medical Center, Washington, DC 20307, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S.